Cash Flow Stella Pharma Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-137.00
-760.00
-775.00
-764.00
-656.00
-959.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
194.00
-150.00
-84.00
-350.00
-143.00
19.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
140.00
-876.00
-827.00
-1,081.00
-772.00
-913.00
Cash Flow from Investing Activities
287.00
-9.00
-29.00
-350.00
-22.00
1,557.00
Cash Flow from Financing Activities
725.00
228.00
291.00
3,456.00
39.00
-27.00
Net Cash Inflow / Outflow
1,153.00
-657.00
-565.00
2,024.00
-755.00
616.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Stella Pharma Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-137.869
-1273.181
1,136.00
89.17%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
194.4
-62.547
256.00
410.81%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
140.408
-1193.337
1,333.00
111.77%
Cash Flow from Investing Activities
287.576
-12.715
299.00
2361.71%
Cash Flow from Financing Activities
725.781
1460.899
-735.00
-50.32%
Net Cash Inflow / Outflow
1153.766
254.847
899.00
352.73%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 116.01% vs -5.94% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
140.41
-876.84
116.01%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
